Skip to main content

Case 03: Medical Diagnostic AI

Medical Diagnostic AI: is it legal in the EU, the United States and China?

The system on trial: AI-driven diagnostic device. The same product meets three legal realities. Each verdict below is an editorial summary of the instruments cited under it, so every claim can be checked against the official text in one click.

EU: HEAVILY REGULATED. US: HEAVILY REGULATED. CN: LICENSED: FILING REQUIRED

European Union

Medical Diagnostic AI: how does the European Union treat it?

HEAVILY REGULATED. Automatic high-risk via the device route. AI needing third-party conformity assessment under the MDR/IVDR is automatically high-risk (Art. 6(1) + Annex I): one integrated CE/Notified-Body route. AI-Act application is deferred to 2 Aug 2028; the MDR itself fully applies today.

HEAVILY REGULATED means: Legal, but gated by conformity, licensing, oversight and documentation duties.

Source: Art. 6(1): AI Act: device-route high-risk; Reg. 2026/1744: Digital Omnibus on AI

United States

Medical Diagnostic AI: how does the United States treat it?

HEAVILY REGULATED. The FDA is America's most mature AI regulator. Full premarket review (510(k)/De Novo/PMA) with lifecycle and bias expectations; 1,247+ AI devices authorized, roughly 76 to 80% in radiology. PCCP guidance lets models update pre-authorized.

HEAVILY REGULATED means: Legal, but gated by conformity, licensing, oversight and documentation duties.

Source: FDA: FDA AI-Enabled Medical Devices; PCCP 2024: FDA Predetermined Change Control Plans

China

Medical Diagnostic AI: how does China treat it?

LICENSED: FILING REQUIRED. NMPA device registration, typically Class III. Pre-market registration, clinical validation and lifecycle oversight; the first AI diagnostic was approved in 2020, with 50+ deep-learning devices on the market by 2023.

LICENSED: FILING REQUIRED means: Must register with the state and pass review before launch.

Source: NMPA: NMPA medical device registration; S30: Chambers Healthcare AI 2025: China

The trapdoor

A hospital-facing GenAI chatbot additionally triggers a CAC GenAI filing: device registration alone isn't enough.

The other 5 cases on the board

Read the regimes behind these verdicts

Knowing the verdict is step one. Passing the assessment is the job.

The programs teach the work that follows: classification calls, conformity assessment, filings, documentation, and the judgment to defend every decision.

VERIFIED 29 JUL 2026. The verdicts are editorial summaries of the instruments cited above, not rulings. Study aid, not legal advice: the official texts are always authoritative.